首页> 外文期刊>The Journal of Organic Chemistry >Diastereoselective Syntheses of Spiro[indoline-3,4 '-pyridin]-2-yl Carbamates via AgOTf/Ph3P-Catalyzed Tandem Cyclizations of Tryptamine-Ynesulfonamides
【24h】

Diastereoselective Syntheses of Spiro[indoline-3,4 '-pyridin]-2-yl Carbamates via AgOTf/Ph3P-Catalyzed Tandem Cyclizations of Tryptamine-Ynesulfonamides

机译:通过AgotF / PH3P催化的Tryptamine-ynesulfonamens的刺激/ pH3p催化串联串联旋转的螺旋[吲哚-3,4'-吡啶] -2-基氨基甲酸酯的非对映选择性合成

获取原文
获取原文并翻译 | 示例
       

摘要

Spiro[indoline-3,4'-piperidine] is a significant structural scaffold in numerous polycyclic indole alkaloids with a variety of bioactivities. In this study, a synthetic strategy was developed to access spiro[indoline-3,4'-pyridin]-2-yl carbamate via an AgOTf/ PPh3-catalyzed tandem cyclization of tryptamine-ynesulfonamides. The unique feature of this strategy is the efficient intermolecular capturing of the in situ generated spiroindoleninium intermediates with carbamates, leading to the diastereoselective syntheses of spiro[indoline-3,4'-pyridin]-2-yl carbamate derivatives. A broad scope of this cyclization was demonstrated by a variety of tryptamine-ynesulfonamide substrates and several carbamates. A plausible mechanism of this reaction was proposed.
机译:螺旋[吲哚啉-3,4'-哌啶]是许多多环吲哚生物碱的重要结构支架,具有多种生物活体。 在这项研究中,开发了一种合成策略,通过Totpotam-ynesulfonamides的Agotf / PPH3催化的串联环化进入螺氧化物 - 氨基甲酸酯。 该策略的独特特征是使用氨基甲酸盐的原位生成螺吲哚喹啉中间体的有效分子捕获,导致螺氧β-吡啶胺衍生物的非对映选择性合成。 通过各种TrictaMine-ynesulfonamide底物和几种氨基甲酸酯证明了这种环化的广泛范围。 提出了这种反应的合理机制。

著录项

  • 来源
    《The Journal of Organic Chemistry》 |2020年第5期|共10页
  • 作者单位

    Shenyang Pharmaceut Univ Minist Educ Key Lab Struct Based Drug Design &

    Discovery Shenyang 110016 Peoples R China;

    Shenyang Pharmaceut Univ Minist Educ Key Lab Struct Based Drug Design &

    Discovery Shenyang 110016 Peoples R China;

    Shenyang Pharmaceut Univ Minist Educ Key Lab Struct Based Drug Design &

    Discovery Shenyang 110016 Peoples R China;

    Shenyang Pharmaceut Univ Minist Educ Key Lab Struct Based Drug Design &

    Discovery Shenyang 110016 Peoples R China;

    Shenyang Pharmaceut Univ Minist Educ Key Lab Struct Based Drug Design &

    Discovery Shenyang 110016 Peoples R China;

    Shenyang Pharmaceut Univ Minist Educ Key Lab Struct Based Drug Design &

    Discovery Shenyang 110016 Peoples R China;

    Shenyang Pharmaceut Univ Minist Educ Key Lab Struct Based Drug Design &

    Discovery Shenyang 110016 Peoples R China;

    Shenyang Pharmaceut Univ Minist Educ Key Lab Struct Based Drug Design &

    Discovery Shenyang 110016 Peoples R China;

    Shenyang Pharmaceut Univ Minist Educ Key Lab Struct Based Drug Design &

    Discovery Shenyang 110016 Peoples R China;

    Shenyang Pharmaceut Univ Minist Educ Key Lab Struct Based Drug Design &

    Discovery Shenyang 110016 Peoples R China;

  • 收录信息
  • 原文格式 PDF
  • 正文语种 eng
  • 中图分类 有机化学;
  • 关键词

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号